U.S. market Closed. Opens in 6 hours 5 minutes

PDSB | PDS Biotechnology Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue57.33K49.08K246.39K176.29K98.41KN/AN/AN/AN/AN/AN/A
Gross Profit-57.33K-49.08K-246.39K-176.29K-98.41KN/AN/AN/AN/AN/AN/A
Operating Expenses43.05M41.67M21.44M14.90M17.08M30.36M51.97M39.51M26.50MN/AN/A
Selling, General & Admin15.28M12.24M10.18M6.96M10.98M14.29M17.65M14.69M8.66M4.72M2.00M
Research & Development27.76M29.43M11.25M7.92M6.10M16.07M34.31M24.83M17.84M8.47M4.48M
Other Operating Expenses0N/AN/A15.61K3.95B12.74BN/AN/AN/AN/AN/A
Operating Income-43.05M-41.67M-21.44M-14.90M-21.03M-43.10M-51.97M-39.51M-26.50M-13.19M-6.49M
Other Expenses / Income-1.30M-381.34K4.35K55.01K13.65M-12.74M-1.48M-1.15M-2.69M402.12K-853.74K
Before Tax Income-44.35M-42.05M-21.43M-14.85M-7.38M-43.65M-53.45M-40.67M-29.19M-12.79M-7.34M
Income Tax Expenses1.41M-1.20M-4.52M-135.68K-381.51K-2.78M-2.59M-1.85M-1.11M-590.67K-459.02K
Net Income-42.94M-40.85M-16.92M-14.85M-7.00M-40.87M-50.86M-38.82M-28.08M-12.20M-6.88M
Interest Expenses4.21M1.32MN/AN/A33.56K1.43M2.18M1.20M816.49K183.18K3.35K
Basic Shares Outstanding30.95M28.60M25.60M16.75M4.87M1.56M1.52M1.44M404.40K418.96K755.36K
Diluted Shares Outstanding30.95M28.60M25.60M16.75M4.87M1.56M1.52M1.44M404.40K418.96K755.36K
EBITDA-42.99M-40.74M-21.43M-14.83M-16.73M-29.31M-51.08M-39.41M-26.45M-13.16M-6.48M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-37.33M-40.74M-21.43M-14.98M-7.35M-42.22M-51.27M-39.46M-28.37M-12.61M-7.34M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙